These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of iron chelator, hydroxyl radical scavenger and cytochrome P450 inhibitors on the cytotoxicity of cisplatin to tumor cells.
    Author: Liu H, Baliga R.
    Journal: Anticancer Res; 2000; 20(6B):4547-50. PubMed ID: 11205302.
    Abstract:
    BACKGROUND: Iron catalyzed reactive oxygen metabolites (ROM) are important mediators in cisplatin (CP)-induced nephrotoxicity, and cytochrome P450 (CYP) is the major source of this iron. Iron chelators, hydroxyl radical scavengers and CYP inhibitors have shown marked protection. MATERIAL AND METHODS: This study was designed to determine whether these agents affect the tumoricidal efficacy of CP to LLC-WRC 256 tumor cells. RESULTS: CP was cytotoxic to the tumor cells in a dose and time dependent manner. Iron chelator, hydroxyl radical scavenger and CYP inhibitors did not reduce the cytotoxic effect of CP. Exposure of the tumor cells to CP did not increase the catalytic iron release and the generation of hydroxyl radical. Both CYP activity and content in the tumor cells were less than 10% of that in the rat liver. CONCLUSION: We speculate that iron chelator, hydroxyl radical scavenger and CYP inhibitors do not alter the antitumor efficacy of CP.
    [Abstract] [Full Text] [Related] [New Search]